Nivolumab
15-126
Phase 2 small_molecule completed
Quick answer
Nivolumab for Bladder Cancer is a Phase 2 program (small_molecule) at Adaptive Biotechnologies Corp with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Adaptive Biotechnologies Corp
- Indication
- Bladder Cancer
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed